These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28549030)

  • 1. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
    Khazai L; Agosto-Arroyo E; Rosa M
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.
    Kővári B; Szász AM; Kulka J; Marušić Z; Šarčević B; Tiszlavicz L; Cserni G
    Pathobiology; 2015 Sep; 82(3-4):166-71. PubMed ID: 26330357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
    Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
    Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
    Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
    J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
    Ren S; Abuel-Haija M; Khurana JS; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
    Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 expression in benign and malignant breast lesions.
    Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
    Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors.
    Owosho AA; Aguilar CE; Seethala RR
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
    Hill CB; Yeh IT
    Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
    Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
    Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate Synthase, a New Myoepithelial Biomarker for Breast Lesions.
    Guo R; Tian Y; Jin X; Huang X; Yang J
    Int J Surg Pathol; 2019 Dec; 27(8):852-858. PubMed ID: 31234664
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
    Alkhayyat R; Abbas A; Quinn CM; Rakha EA
    Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
    Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
    Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.